CRISPR Therapeutics (CRSP) has been on many watchlists after a choppy few months, and the stock’s recent slide is prompting investors to revisit whether the current price still makes sense. See our ...

CRISPR Therapeutics (NASDAQ: CRSP) has had a volatile performance over the past five years. While its stock is up more than ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

According to Benzinga Pro, CRISPR Therapeutics AG's peer group average for short interest as a percentage of float is 14.28%, ...

As of Wednesday, December 17, EUDA Health Holdings Limited’s EUDA share price has surged by 5.42%, which has investors ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics ( CRSP 0.76%) and Viking Therapeutics ( VKTX ...

The following players span a variety of industries, so if you pick up more than one, you may gain in diversification.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Intellia Therapeutics finds itself navigating turbulent waters, with its stock price hitting fresh lows as a combination of clinical setbacks and insider sel ...

On Dec. 15, 17, and 18, Wood’s Ark funds bought 106,530 shares of Coinbase Global Inc. ( COIN ), valued at about $26.1 ...

Shares of Medline, a medical-supplies manufacturer and distributor, rose 41% in their trading debut Wednesday after the ...